PolyActiva reports promising Phase 2a clinical trial results
PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients. The interim Phase 2a results demonstrate a sustained >20% reduction of IOP…